glp 1 receptor function GLP-1 agonists for individualized treatment of type 2 diabetes mellitus GLP-1 Receptor Agonists | New

The kainic acid model of temporal lobe epilepsy

Minimizing hypoglycemia in diabetes

The gradual dose titration schedule recommended for Mounjarostarting at 2.5 mg weekly and increasing every four weeksis specifically designed to minimise gastrointestinal intolerance

PlexusDx supports a precision-wellness approach that combines clinical safety data, individual health context, and provider collaboration to help you make informed decisions aligned with your family's needs

Survodutide, developed by Boehringer Ingelheim and Zealand Pharma with both FDA Fast Track and Breakthrough Therapy designations, is a glucagon/GLP-1 dual agonist that achieved 16.6% placebo-adjusted weight reduction at 76 weeks

Many foods also contain added vitamin A, including cereals, margarine, and dairy products